By Justine R. Smith, MD, PhD
Edited by: Justine R. Smith, MD, PhD
American Uveitis Society AAO Education Liaison
The following 12 uveitis papers published in 2014 were selected by members of the American Uveitis Society (AUS) for their outstanding teaching value for residents:
Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH. Factors predictive of remission of new-onset anterior uveitis. Ophthalmology. 2014;121:778-84.
Grange LK, Kouchouk A, Dalal MD, Vitale S, Nussenblatt RB, Chan CC, Sen HN. Neoplastic masquerade syndromes in patients with uveitis. Am J Ophthalmol. 2014;157:526-31.
Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785-96.
Mehta S, Linton MM, Kempen JH. Outcomes of cataract surgery in patients with uveitis: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158:676-692.
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis. Ophthalmology. 2014;121:1855-62.
Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE. Tattoo-associated uveitis. Am J Ophthalmol. 2014;158:637-43.
Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014;121:1863-70.
Sen HN, Vitale S, Gangaputra SS, Nussenblatt RB, Liesegang TL, Levy-Clarke GA, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Kempen JH. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology. 2014;121:2275-86.
Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint Sardos A, Butler NJ, Smith JR, Rosenbaum JT. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial. Ophthalmology. 2014;121:1885-91.
Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr. Viral retinitis following intraocular or periocular corticosteroid administration: a case series and comprehensive review of the literature. Ocul Immunol Inflamm. 2014;22:175-82.
Tomkins-Netzer O, Talat L, Bar A, Lula A, Taylor SR, Joshi L, Lightman S. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121:2387-92.
Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency. Am J Ophthalmol. 2014;158:1136-1145.
An American Uveitis Society Publication
Contributors:
Nisha Acharya, MD, MS; Pooja Bhat, MD; Nicholas J. Butler, MD; David Callanan, MD; Janet L. Davis, MD; James P. Dunn, MD; Anthony S. Ekong, MD; C. Stephen Foster, MD; Debra A. Goldstein, MD; John A. Gonzales, MD; Guy Jirawuthiworavong, MD, MA; Kashyap Kansupada, MD, FACS; Henry J. Kaplan, MD; Adam H. Kaufman, MD; Sanjay R. Kedhar, MD; Shree K. Kurup, MD; Kelly L. Larkin, MD; Paul Latkany, MD; Shelly T. Lee, MD; Ralph Levinson, MD; Grace A. Levy-Clarke MD; Helen K. Li, MD; Careen Y. Lowder, MD; Todd P. Margolis, MD, PhD; Virginia Miraldi Utz, MD; Ramana S. Moorthy, MD; Quan D. Nguyen, MD; E. Mitchel Opremcak, MD; Alan G. Palestine, MD; George N. Papaliodis, MD; Narsing A. Rao, MD; Russell W. Read, MD, PhD; Ashvini K. Reddy, MD; Nehali V. Saraiya, MD; Shlomit Schaal, MD, PhD; Anita P. Schadlu, MD; Mark D. Sherman; Jerry A. Shields; Justine R. Smith, FRANZCO, PhD; Wendy M. Smith, MD; Howard H. Tessler, MD; Jennifer E. Thorne, MD, PhD; Eduardo Uchiyama, MD; Jonathan Walker, MD; Christopher Walton, MD; James M. Weisz, MD.
Acknowledgement:
The American Uveitis Society thanks Ms. Deb Sullivan for her administrative assistance in preparing this publication.